Condition

Age-Related Macular Degeneration (AMD) clinical trials and research

• 12Clinical trials
• 16Countries

Newest Age-Related Macular Degeneration (AMD) clinical trials

All recruiting trials (12)

• Enhanced vision and imaging tests to enable treatments for early and intermediate AMD

  We will see if a fundus-tracked dark adaptometry test can reliably detect and track vision changes in people with early or intermediate AMD and in healthy volunteers.

  Recruiting University Hospital, Bonn · Bonn · NCT07515521

• Finding protein biomarkers for AMD, diabetic retinopathy, and retinal detachment

  This project will test whether proteins found in blood and eye fluids can help diagnose or predict outcomes for adults with AMD, diabetic retinopathy, or retinal detachment.

  Recruiting Fondazione G.B. Bietti, IRCCS · Roma, Italy · NCT07500324

• Early response to Eylea 8 mg in neovascular (wet) age-related macular degeneration

  This observational project will try Eylea (aflibercept) 8 mg eye injections to see how retinal fluid and vision change over the first two months in people with active neovascular AMD.

  Recruiting Insel Gruppe AG, University Hospital Bern · Bern · NCT07434713

• SING IMT implant for pseudophakic patients with advanced AMD

  This study will test whether the SING IMT™ implant, placed either on top of or replacing an existing intraocular lens, can improve central vision in people with advanced AMD who already have IOLs.

  Recruiting at 12 sites VisionCare, Inc. · Marseille and 11 other locations · NCT07164378

• iPredict: automated AI for early detection and prediction of late age-related macular degeneration

  iPredict will be tried to detect early signs and predict the risk of late AMD using non-dilated eye photos taken in primary care or general ophthalmology offices for adults without a prior AMD diagnosis.

  Recruiting iHealthScreen Inc · Richmond Hill, New York · NCT07084883

• AI-assisted eye screening for diabetic retinopathy and age-related macular degeneration in outpatient clinics

  This project will test whether the VeriSee AI software helps doctors find diabetic eye disease and macular degeneration earlier in adults with diabetes or people aged 50 and older.

  Recruiting National Taiwan University Hospital · Taipei · NCT07069647

• VeriSee AI for screening macular degeneration and diabetic retinopathy

  This trial will test whether the VeriSee AI software can help doctors screen for age-related macular degeneration in adults 50+ and diabetic retinopathy in diabetic adults 20+.

  Recruiting National Taiwan University Hospital · Taipei, Taiwan · NCT06843499

• ONL1204 injections for geographic atrophy from age-related macular degeneration

  This trial will try intravitreal ONL1204 injections at two doses and two schedules in people 55 and older with geographic atrophy from AMD to see if it slows lesion growth and is safe.

  Recruiting at 120 sites Phase 2 ONL Therapeutics · Gilbert, Arizona and 119 other locations · NCT06659445

• Investigating a new treatment for geographic atrophy in age-related macular degeneration

  This study is testing a new treatment using two drugs to see if they can slow down the worsening of geographic atrophy in adults with age-related macular degeneration.

  Recruiting at 220 sites Phase 3 Regeneron Pharmaceuticals · Chandler, Arizona and 232 other locations · NCT06541704

• Exercise program to improve vision and health in Veterans with AMD

  This study is testing whether a stationary biking exercise program can help improve vision and overall health in Veterans with age-related macular degeneration.

  Recruiting VA Office of Research and Development · Decatur, Georgia · NCT05932069

• Long-term treatment with Dimethyl Fumarate for geographic atrophy in AMD patients

  This study is testing if a medication called Dimethyl Fumarate can help slow down vision loss in people with geographic atrophy due to age-related macular degeneration.

  Recruiting Phase 2 Assistance Publique - Hôpitaux de Paris · Créteil, Val De Marne · NCT04292080

• Cost-effectiveness of anti-VEGF treatments for newly diagnosed AMD in France

  This study tests whether bevacizumab, ranibizumab, or aflibercept for new neovascular AMD provide good value for money while affecting patients’ quality of life.

  Recruiting Centre Hospitalier Universitaire, Amiens · Amiens · NCT03577041

Related topics

Quick answers

How many Age-Related Macular Degeneration (AMD) clinical trials are recruiting right now?

12, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 16 countries. The most sites are in France (4 trials), Germany (4 trials), United States (4 trials), Italy (3 trials), Taiwan (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →